Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Cash from Operations (2016 - 2025)

Conmed's Cash from Operations history spans 16 years, with the latest figure at 46335000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations rose 6.92% year-over-year to 46335000.0; the TTM value through Dec 2025 reached 170689000.0, up 2.23%, while the annual FY2025 figure was 170689000.0, 2.23% up from the prior year.
  • Cash from Operations reached 46335000.0 in Q4 2025 per CNMD's latest filing, down from 53686000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 56395000.0 in Q4 2023 to a low of 11598000.0 in Q4 2022.
  • Average Cash from Operations over 5 years is 30407000.0, with a median of 31459500.0 recorded in 2021.
  • Peak YoY movement for Cash from Operations: tumbled 1272.87% in 2023, then surged 856.98% in 2024.
  • A 5-year view of Cash from Operations shows it stood at 33785000.0 in 2021, then crashed by 134.33% to 11598000.0 in 2022, then skyrocketed by 586.25% to 56395000.0 in 2023, then dropped by 23.15% to 43338000.0 in 2024, then rose by 6.92% to 46335000.0 in 2025.
  • Per Business Quant, the three most recent readings for CNMD's Cash from Operations are 46335000.0 (Q4 2025), 53686000.0 (Q3 2025), and 29134000.0 (Q2 2025).